To assess the perceived importance of DEI among registrants and the barriers they experience in promoting fundamental changes.
The 2020 CTSA Fall Program Meeting Diversity, Equity, and Inclusion (DEI) session organizers aimed to better understand DEI issues in regards to Workforce Development, CTSA Consortium Leadership, Disparities/Health Equity Research, and Clinical Trials Participation.
On November 12, 2020 a pre-meeting poll was sent to all CTSA Fall Program Meeting registrants. This report of the evaluation questions addresses Diversity, Equity, and Inclusion (DEI) efforts and issues institutionally and structurally. An initial email request with two reminders were sent to meeting registrants. A total of 231 responses were received from the meeting registrants, for a final response rate of 29.02%.
The majority of the evaluation questions were open-ended. Registrants were asked what barriers to DEI efforts were present in respect to clinical and translational science, and also what their recommendations were for solutions to those barriers. The barriers and recommendations most often mentioned include Recruitment, Funding, Applicant Pools, and Institutional Policies and Priorities.
The majority of respondents identified themselves as an “Other” regarding their role or position (50.6%). UL1 Executive Director/Administrator (15.2%) and UL1 PI (13.0%) were the next highest respondent roles.
The majority of the respondents (93.5%) said that DEI was either extremely important or very important to them. Similarly, the majority of respondents (86.2%) said that they were either extremely committed or very committed to improving DEI efforts within the Consortium.
Please log in to access this content